Literature DB >> 11007812

Is there a role for locally produced complement in renal disease?

M R Daha, C van Kooten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11007812     DOI： 10.1093/ndt/15.10.1506

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

1.  Complement Factor B Production in Renal Tubular Cells and Its Role in Sodium Transporter Expression During Polymicrobial Sepsis.

Authors:  Dan Li; Lin Zou; Yan Feng; Ganqiong Xu; Yu Gong; Gaofeng Zhao; Wen Ouyang; Joshua M Thurman; Wei Chao
Journal:  Crit Care Med       Date:  2016-05       Impact factor: 7.598

Review 2.  Crescents and IgA Nephropathy: A Delicate Marriage.

Authors:  Hernán Trimarchi; Mark Haas; Rosanna Coppo
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

3.  Proteomics of Urinary Vesicles Links Plakins and Complement to Polycystic Kidney Disease.

Authors:  Mahdi Salih; Jeroen A Demmers; Karel Bezstarosti; Wouter N Leonhard; Monique Losekoot; Cees van Kooten; Ron T Gansevoort; Dorien J M Peters; Robert Zietse; Ewout J Hoorn
Journal:  J Am Soc Nephrol       Date:  2016-03-03       Impact factor: 10.121

4.  Role of complement 3 in TNF-α-induced mesenchymal transition of renal tubular epithelial cells in vitro.

Authors:  Jianxin Wan; Xueli Zhou; Jiong Cui; Zhenhuan Zou; Yanfang Xu; Danyu You
Journal:  Mol Biotechnol       Date:  2013-05       Impact factor: 2.695

Review 5.  The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?

Authors:  Felix Poppelaars; Bernardo Faria; Wilhelm Schwaeble; Mohamed R Daha
Journal:  J Clin Med       Date:  2021-10-14       Impact factor: 4.241

Review 6.  Crescents in primary glomerulonephritis: a pattern of injury with dissimilar actors. A pathophysiologic perspective.

Authors:  Hernán Trimarchi
Journal:  Pediatr Nephrol       Date:  2021-07-27       Impact factor: 3.651
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.